GlassScriptPhysician profile
Michael A Ficazzola
NPI 1053336263
$16,038.94
in general payments reported to CMS, 2019-2025
52 companies · $2,667 in 2025
The $2,667 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,987 · 2020: $902 · 2021: $2,370 · 2022: $2,393 · 2023: $2,418 · 2024: $3,302 · 2025: $2,667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,358 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $950 · Travel and Lodging: $69.96 · Education: $8.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,358.35 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $950.00 |
| Travel and Lodging | $69.96 |
| Education | $8.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,665.24 | 2019-2025 | |
| Astellas Pharma US INC | $1,663.34 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Janssen Biotech, INC. | $1,466.66 | 2019-2025 | Erleada, Akeega, Balversa |
| Sumitomo Pharma America, INC. | $1,394.72 | 2023-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $1,149.04 | 2019-2025 | Rezum Generator, Ams 700, Xpeeda Dsl Fiber |
| Dendreon Pharmaceuticals LLC | $957.32 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $778.28 | 2019-2025 | |
| Teleflex LLC | $639.58 | 2021-2025 | Urolift, Barrigel |
| Urovant Sciences INC | $592.98 | 2021-2022 | |
| Urogen Pharma, INC. | $570.68 | 2021-2025 | |
| Antares Pharma, INC. | $477.40 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Endo Pharmaceuticals INC. | $456.15 | 2019-2024 | Xiaflex, Aveed, Edex |
| Neotract INC. | $442.91 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $355.22 | 2020-2025 | Keytruda, Lynparza, Bridion |
| Acerus Pharmaceuticals Corporation | $306.88 | 2020-2022 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $297.83 | 2021-2022 | |
| Abbvie INC. | $229.28 | 2021-2025 | |
| Coloplast Corp | $223.67 | 2021-2025 | Altis, Porges Coloplast |
| Ferring Pharmaceuticals INC. | $214.65 | 2019-2025 | Adstiladrin, Firmagon |
| Myriad Genetic Laboratories, INC. | $213.70 | 2021-2025 | Prolaris |
| Kerecis Limited | $194.21 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Procept Biorobotics Corporation | $189.99 | 2019-2023 | Aquabeam Robotic System |
| Blue Earth Diagnostics | $161.06 | 2019-2023 | |
| Tolmar, INC. | $154.83 | 2023-2025 | Eligard, Jatenzo |
| Progenics Pharmaceuticals, INC. | $142.00 | 2023-2025 | Pylarify |
| Endo USA, INC. | $132.74 | 2024-2025 | Xiaflex, Aveed, Edex |
| Medtronic USA, INC. | $101.74 | 2019 | |
| Olympus America INC. | $93.84 | 2021-2025 | Itind System |
| Edap Technomed INC | $81.00 | 2024 | |
| Amgen INC. | $73.16 | 2019-2021 | |
| Allergan, INC. | $53.76 | 2019-2020 | |
| Accord Healthcare, INC. | $49.73 | 2023-2025 | |
| Foundation Medicine, INC. | $44.49 | 2020 | |
| Halozyme INC | $43.43 | 2023 | |
| Clarus Therapeutics INC. | $43.16 | 2021 | |
| Photocure INC | $40.72 | 2022-2025 | Cysview |
| Axonics, INC. | $38.81 | 2022-2023 | Bulkamid |
| Dentsply Ih INC. | $33.80 | 2021-2022 | |
| Medtronic, INC. | $28.30 | 2025 | Interstim |
| Bioprotect Medical, INC. | $24.98 | 2024 | Bioprotect Balloon Implant System |
| Therapeuticsmd, INC. | $24.78 | 2019 | |
| Lantheus Medical Imaging, INC. | $22.62 | 2024 | |
| Genzyme Corporation | $20.75 | 2022 | |
| Karl Storz Endoscopy-America | $20.40 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $20.00 | 2019 | |
| Axogen | $18.71 | 2022 | |
| Novartis Pharmaceuticals Corporation | $18.56 | 2019 | |
| Travere Therapeutics, INC. | $17.96 | 2019 | |
| Alnylam Pharmaceuticals INC. | $15.56 | 2023 | Givlaari |
| Verity Pharmaceuticals INC. | $13.57 | 2025 | Trelstar |
| C. R. Bard, INC. & Subsidiaries | $13.15 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ficazzola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.